Literature DB >> 24009219

Changes in body weight and subsequent mortality: are we any closer to knowing how to deal with obesity in ESRD?

Csaba P Kovesdy1, Kamyar Kalantar-Zadeh.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24009219      PMCID： PMC3789350          DOI： 10.2215/CJN.08260813

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  22 in total

1.  The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis.

Authors:  Kamyar Kalantar-Zadeh; Elani Streja; Csaba P Kovesdy; Antigone Oreopoulos; Nazanin Noori; Jennie Jing; Allen R Nissenson; Mahesh Krishnan; Joel D Kopple; Rajnish Mehrotra; Stefan D Anker
Journal:  Mayo Clin Proc       Date:  2010-11       Impact factor: 7.616

2.  Associations of body fat and its changes over time with quality of life and prospective mortality in hemodialysis patients.

Authors:  Kamyar Kalantar-Zadeh; Noriko Kuwae; Dennis Y Wu; Ronney S Shantouf; Denis Fouque; Stefan D Anker; Gladys Block; Joel D Kopple
Journal:  Am J Clin Nutr       Date:  2006-02       Impact factor: 7.045

3.  Mortality prediction by surrogates of body composition: an examination of the obesity paradox in hemodialysis patients using composite ranking score analysis.

Authors:  Kamyar Kalantar-Zadeh; Elani Streja; Miklos Z Molnar; Lilia R Lukowsky; Mahesh Krishnan; Csaba P Kovesdy; Sander Greenland
Journal:  Am J Epidemiol       Date:  2012-03-16       Impact factor: 4.897

4.  Associations of body mass index and weight loss with mortality in transplant-waitlisted maintenance hemodialysis patients.

Authors:  M Z Molnar; E Streja; C P Kovesdy; S Bunnapradist; M S Sampaio; J Jing; M Krishnan; A R Nissenson; G M Danovitch; K Kalantar-Zadeh
Journal:  Am J Transplant       Date:  2011-04       Impact factor: 8.086

5.  Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction.

Authors:  Kamyar Kalantar-Zadeh; Ryan D Kilpatrick; Noriko Kuwae; Charles J McAllister; Harry Alcorn; Joel D Kopple; Sander Greenland
Journal:  Nephrol Dial Transplant       Date:  2005-06-14       Impact factor: 5.992

6.  Influence of body mass index on the association of weight changes with mortality in hemodialysis patients.

Authors:  Iván Cabezas-Rodriguez; Juan Jesús Carrero; Carmine Zoccali; Abdul Rashid Qureshi; Markus Ketteler; Jürgen Floege; Gérard London; Francesco Locatelli; José Luis Gorriz; Boleslaw Rutkowski; Dimitrios Memmos; Anibal Ferreira; Adrian Covic; Vladimir Teplan; Willem-Jan Bos; Reinhard Kramar; Drasko Pavlovic; David Goldsmith; Judit Nagy; Miha Benedik; Dierik Verbeelen; Christian Tielemans; Rudolf P Wüthrich; Pierre-Yves Martin; Carlos Martínez-Salgado; José Luis Fernández-Martín; Jorge B Cannata-Andia
Journal:  Clin J Am Soc Nephrol       Date:  2013-09-05       Impact factor: 8.237

7.  Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population.

Authors:  Kamyar Kalantar-Zadeh; Joel D Kopple; Ryan D Kilpatrick; Charles J McAllister; Christian S Shinaberger; David W Gjertson; Sander Greenland
Journal:  Am J Kidney Dis       Date:  2005-09       Impact factor: 8.860

Review 8.  Survival advantages of obesity in dialysis patients.

Authors:  Kamyar Kalantar-Zadeh; Kevin C Abbott; Abdulla K Salahudeen; Ryan D Kilpatrick; Tamara B Horwich
Journal:  Am J Clin Nutr       Date:  2005-03       Impact factor: 7.045

Review 9.  Adiposity in dialysis: good or bad?

Authors:  Allon N Friedman
Journal:  Semin Dial       Date:  2006 Mar-Apr       Impact factor: 3.455

10.  Why cachexia kills: examining the causality of poor outcomes in wasting conditions.

Authors:  Kamyar Kalantar-Zadeh; Connie Rhee; John J Sim; Peter Stenvinkel; Stefan D Anker; Csaba P Kovesdy
Journal:  J Cachexia Sarcopenia Muscle       Date:  2013-06-08       Impact factor: 12.910
View more
  1 in total

Review 1.  Obesity paradox in end-stage kidney disease patients.

Authors:  Jongha Park; Seyed-Foad Ahmadi; Elani Streja; Miklos Z Molnar; Katherine M Flegal; Daniel Gillen; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Prog Cardiovasc Dis       Date:  2013-10-09       Impact factor: 8.194
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.